{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:10Z","timestamp":1792510930154,"version":"4.5.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope On Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000938","name":"Robert E. Leet and Clara Guthrie Patterson Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000938","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Chemotherapy induced peripheral neuropathy (CIPN) is an often severe and debilitating complication of multiple chemotherapeutic agents that can affect patients of all ages, across cancer diagnoses. CIPN can persist post-therapy, and significantly impact the health and quality of life of cancer survivors. Identifying patients at risk for CIPN is challenging due to the lack of standardized objective measures to assess for CIPN. Furthermore, there are no approved preventative treatments for CIPN, and therapeutic options for CIPN remain limited once it develops. Biomarkers of CIPN have been studied but are not widely used in clinical practice. They can serve as an important clinical tool to identify individuals at risk for CIPN and to better understand the pathogenesis and avenues for treatment of CIPN. Here we review promising biomarkers of CIPN in humans and their clinical implications.<\/jats:p>","DOI":"10.3389\/fpain.2022.864910","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:44:25Z","timestamp":1647218665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions"],"prefix":"10.3389","volume":"3","author":[{"given":"Rozalyn L.","family":"Rodwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrah Z.","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam B.","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S2352-4642(18)30236-0","article-title":"Peripheral neuropathy in children and adolescents treated for cancer","volume":"2","author":"Bjornard","year":"2018","journal-title":"Lancet Child Adolesc Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/0284186X.2021.1917776","article-title":"Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life","volume":"60","author":"Eikeland","year":"2021","journal-title":"Acta Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1002\/cam4.4289","article-title":"The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer","volume":"10","author":"van de Velde","year":"2021","journal-title":"Cancer Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/1043454216651016","article-title":"Challenges evaluating chemotherapy-induced peripheral neuropathy in childhood cancer survivors","volume":"34","author":"Mohrmann","year":"2017","journal-title":"J Pediatr Oncol Nurs."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E111","DOI":"10.1188\/17.ONF.E111-E123","article-title":"Chemotherapy-induced peripheral neuropathy assessment tools: a systematic review","volume":"44","author":"Haryani","year":"2017","journal-title":"Oncol Nurs Forum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","article-title":"Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy","volume":"307","author":"Meregalli","year":"2018","journal-title":"Exp Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.1038\/s41598-020-64511-5","article-title":"Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/331261a0","article-title":"Brain-derived neurotrophic factor prevents neuronal death in vivo","volume":"331","author":"Hofer","year":"1988","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1196\/annals.1403.009","article-title":"Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity","volume":"1122","author":"Lipsky","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bjh.12624","article-title":"Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma","volume":"164","author":"Azoulay","year":"2014","journal-title":"Br J Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/bjh.16862","article-title":"Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients","volume":"191","author":"Szudy-Szczyrek","year":"2020","journal-title":"Br J Haematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.15428","article-title":"Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma","volume":"185","author":"Azoulay","year":"2019","journal-title":"Br J Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3988\/jcn.2019.15.4.511","article-title":"Prediction of chemotherapy-induced peripheral neuropathy in patients with lymphoma and myeloma: the roles of brain-derived neurotropic factor protein levels and A gene polymorphism","volume":"15","author":"Azoulay","year":"2019","journal-title":"J Clin Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10549-015-3546-5","article-title":"Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy","volume":"153","author":"Azoulay","year":"2015","journal-title":"Breast Cancer Res Treat."},{"key":"B21","unstructured":"BDNF Val66Met is associated with pre-existing but not with paclitaxel-induced peripheral neuropathy in an Israeli cohort of breast cancer patients7468\n            LeiboviciA\n            SharonR\n            AzoulayD\n          30550003Isr Med Assoc J.202018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1479-5876-10-239","article-title":"Nerve growth factor: from the early discoveries to the potential clinical use","volume":"10","author":"Aloe","year":"2012","journal-title":"J Transl Med."},{"key":"B23","unstructured":"Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor905\n            De SantisS\n            PaceA\n            BoveL\n            CognettiF\n            ProperziF\n            FioreM\n          10656436Clin Cancer Res.62000"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","article-title":"Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy","volume":"15","author":"Cavaletti","year":"2004","journal-title":"Ann Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0183491","DOI":"10.1371\/journal.pone.0183491","article-title":"Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies","volume":"12","author":"Youk","year":"2017","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2013-305334","article-title":"Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients","volume":"85","author":"Velasco","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4049098","DOI":"10.1155\/2017\/4049098","article-title":"Osteopontin at the crossroads of inflammation and tumor progression","volume":"2017","author":"Castello","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0190252","DOI":"10.1371\/journal.pone.0190252","article-title":"Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: a systematic review and meta-analysis","volume":"13","author":"Agah","year":"2018","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1523\/JNEUROSCI.3822-13.2014","article-title":"Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration","volume":"34","author":"Wright","year":"2014","journal-title":"J Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neucli.2019.12.001","article-title":"Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients","volume":"50","author":"Pizzamiglio","year":"2020","journal-title":"Neurophysiol Clin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7949","DOI":"10.1111\/jcmm.15427","article-title":"Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"24","author":"Kalynovska","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1523\/JNEUROSCI.3708-15.2016","article-title":"CD8+ T cells and endogenous IL-10 are required for resolution of chemotherapy-induced neuropathic pain","volume":"36","author":"Krukowski","year":"2016","journal-title":"J Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.21873\/anticanres.12160","article-title":"The relationship between peripheral neuropathy induced by docetaxel and systemic inflammation-based parameters in patients with breast cancer","volume":"37","author":"Yamanouchi","year":"2017","journal-title":"Anticancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10549-021-06304-6","article-title":"Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy","volume":"189","author":"Kleckner","year":"2021","journal-title":"Breast Cancer Res Treat."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0210995","DOI":"10.1371\/journal.pone.0210995","article-title":"Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice","volume":"14","author":"Peng","year":"2019","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"37907","DOI":"10.1074\/jbc.M112.385070","article-title":"Inhibition of paclitaxel-induced decreases in calcium signaling","volume":"287","author":"Benbow","year":"2012","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0145816","DOI":"10.1371\/journal.pone.0145816","article-title":"Identifying predictors of taxane-induced peripheral neuropathy using mass spectrometry-based proteomics technology","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2015.0894","article-title":"Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia","volume":"313","author":"Diouf","year":"2015","journal-title":"JAMA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/cpt.506","article-title":"An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia","volume":"101","author":"Stock","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/cpt.1179","article-title":"Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes","volume":"105","author":"Wright","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/a-1213-5995","article-title":"Association of CEP72 rs924607 TT genotype with vincristine-induced peripheral neuropathy measured by motor nerve conduction studies","volume":"232","author":"Kav\u010di\u010d","year":"2020","journal-title":"Klin Padiatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-13-3232","article-title":"Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel","volume":"20","author":"Abraham","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/annonc\/mdx491","article-title":"Clinical and genetic predictors of paclitaxel neurotoxicity based on patient-versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial","volume":"28","author":"Park","year":"2017","journal-title":"Ann Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2217\/pgs.14.68","article-title":"Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia","volume":"15","author":"Ceppi","year":"2014","journal-title":"Pharmacogenomics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pbc.22845","article-title":"Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr Blood Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.2147\/OTT.S106574","article-title":"Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel","volume":"9","author":"Kus","year":"2016","journal-title":"Onco Targets Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdt018","article-title":"CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel","volume":"24","author":"Hertz","year":"2013","journal-title":"Ann Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/cpt.1391","article-title":"Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in patients with breast cancer: a case-control study","volume":"106","author":"Arbitrio","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00280-017-3314-9","article-title":"Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese","volume":"79","author":"Tanabe","year":"2017","journal-title":"Cancer Chemother Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2217\/pgs-2016-0001","article-title":"Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia","volume":"17","author":"Lopez-Lopez","year":"2016","journal-title":"Pharmacogenomics."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1158\/1078-0432.CCR-07-4230","article-title":"ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel","volume":"14","author":"Sissung","year":"2008","journal-title":"Clin Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11064-016-2007-9","article-title":"Genetic susceptibility to bortezomib-induced peripheral neuroropathy: replication of the reported candidate susceptibility loci","volume":"42","author":"Campo","year":"2017","journal-title":"Neurochem Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65\/GMMG-HD4 trial","volume":"11","author":"Broyl","year":"2010","journal-title":"Lancet Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/annonc\/mdt546","article-title":"Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study","volume":"25","author":"Custodio","year":"2014","journal-title":"Ann Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/FPC.0b013e3283436b45","article-title":"Genetic variation associated with bortezomib-induced peripheral neuropathy","volume":"21","author":"Favis","year":"2011","journal-title":"Pharmacogenet Genomics."},{"key":"B56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12885-020-06834-0","article-title":"Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients","volume":"20","author":"Tanabe","year":"2020","journal-title":"BMC Cancer."},{"key":"B57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12885-016-3031-5","article-title":"Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy","volume":"17","author":"Sereno","year":"2017","journal-title":"BMC Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.22034\/APJCP.2017.18.11.3157","article-title":"Association of voltage-gated sodium channel genetic polymorphisms with oxaliplatin-induced chronic peripheral neuropathy in south indian cancer patients","volume":"18","author":"Palugulla","year":"2017","journal-title":"Asian Pac J Cancer Prev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/cncr.28234","article-title":"Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study","volume":"119","author":"Argyriou","year":"2013","journal-title":"Cancer."},{"key":"B60","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","article-title":"Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199","volume":"21","author":"Schneider","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2217\/pgs-2020-0053","article-title":"Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy","volume":"21","author":"Chen","year":"2020","journal-title":"Pharmacogenomics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1158\/1078-0432.CCR-12-1590","article-title":"A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101","volume":"18","author":"Baldwin","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.24265","article-title":"Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy","volume":"76","author":"Beutler","year":"2014","journal-title":"Ann Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2015.06.056","article-title":"Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)","volume":"357","author":"Boora","year":"2015","journal-title":"J Neurol Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1002\/cncr.26614","article-title":"Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients","volume":"118","author":"Won","year":"2012","journal-title":"Cancer."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/cpt.1324","article-title":"Genetic variants associated with vincristine-induced peripheral neuropathy in two populations of children with acute lymphoblastic leukemia","volume":"105","author":"Li","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ygyno.2021.10.006","article-title":"Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors","volume":"163","author":"Thomaier","year":"2021","journal-title":"Gynecol Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FPC.0000000000000318","article-title":"Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci","volume":"28","author":"Sucheston-Campbell","year":"2018","journal-title":"Pharmacogenet Genomics."},{"key":"B69","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/jmedgenet-2012-101466","article-title":"Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy","volume":"50","author":"Leandro-Garc\u00eda","year":"2013","journal-title":"J Med Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/bcp.14192","article-title":"Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy","volume":"86","author":"Marcath","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/1078-0432.CCR-16-0694","article-title":"Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy","volume":"23","author":"Apell\u00e1niz-Ruiz","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00280-018-3629-1","article-title":"Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients","volume":"82","author":"Palugulla","year":"2018","journal-title":"Cancer Chemother Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"113121","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: a current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/FPC.0000000000000191","article-title":"Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population","volume":"26","author":"Gutierrez-Camino","year":"2016","journal-title":"Pharmacogenet Genomics."},{"key":"B75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/FPC.0000000000000345","article-title":"Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study","volume":"28","author":"Zgheib","year":"2018","journal-title":"Pharmacogenet Genomics."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41397-019-0081-5","article-title":"Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia","volume":"19","author":"Martin-Guerrero","year":"2019","journal-title":"Pharmacogenomics J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zajaczkowska","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/jns.12347","article-title":"Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity","volume":"24","author":"Argyriou","year":"2019","journal-title":"J Peripher Nerv Syst."},{"key":"B79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"Peters","year":"2007","journal-title":"Exp Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1179\/1476830514Y.0000000165","article-title":"Ameliorative potential of ferulic acid in vincristine-induced painful neuropathy in rats: an evidence of behavioral and biochemical examination","volume":"20","author":"Vashistha","year":"2017","journal-title":"Nutr Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.neuro.21.1.309","article-title":"The ephrins and Eph receptors in neural development","volume":"21","author":"Flanagan","year":"1998","journal-title":"Annu Rev Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/jnci\/djaa204","article-title":"Germline cancer-predisposition variants in pediatric rhabdomyosarcoma: a report from the children's oncology group","volume":"113","author":"Li","year":"2021","journal-title":"J Natl Cancer Inst."},{"key":"B83","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/geno.1996.0346","article-title":"Gene structure and chromosome localization to 7q213 of the human rod photoreceptor transducin gamma-subunit gene (GNGT1)","volume":"35","author":"Scherer","year":"1996","journal-title":"Genomics."},{"key":"B84","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4161\/cc.4.4.1607","article-title":"CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?","volume":"4","author":"Lolli","year":"2005","journal-title":"Cell Cycle."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-16-3224","article-title":"Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer","volume":"23","author":"Dolan","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-05-0298","article-title":"Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer","volume":"11","author":"Mielke","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-18-0656","article-title":"Paclitaxel plasma concentration after the first infusion predicts treatment-limiting peripheral neuropathy","volume":"24","author":"Hertz","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B88","first-page":"767","article-title":"Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin","volume":"5","author":"Rowinsky","year":"1999","journal-title":"Clin Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0022-3476(94)70027-3","article-title":"Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia","volume":"125","author":"Crom","year":"1994","journal-title":"J Pediatr."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3390\/cancers12071789","article-title":"Population pharmacokinetics of vincristine related to infusion duration and peripheral neuropathy in pediatric oncology patients","volume":"12","author":"van de Velde","year":"2020","journal-title":"Cancers"},{"key":"B91","first-page":"593","article-title":"Neurotrophic factors in the therapy of peripheral neuropathy","volume":"4","author":"Apfel","year":"1995","journal-title":"Baillieres Clin Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/16078454.2020.1784615","article-title":"The effect of rat nerve growth factor combined with vitamin B on peripheral neuropathy in multiple myeloma patients","volume":"25","author":"Yan","year":"2020","journal-title":"Hematology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.critrevonc.2019.102831","article-title":"Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings","volume":"145","author":"Ibrahim","year":"2020","journal-title":"Crit Rev Oncol Hematol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"18356","DOI":"10.1073\/pnas.0607240103","article-title":"Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism","volume":"103","author":"Boehmerle","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B95","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.0701546104","article-title":"Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation","volume":"104","author":"Boehmerle","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1096\/fj.12-214643","article-title":"Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment","volume":"26","author":"Mo","year":"2012","journal-title":"FASEB J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.18632\/oncotarget.23467","article-title":"The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients","volume":"9","author":"Wadia","year":"2018","journal-title":"Oncotarget."},{"key":"B98","doi-asserted-by":"publisher","first-page":"113607","DOI":"10.1016\/j.expneurol.2021.113607","article-title":"Protection against oxaliplatin-induced mechanical and thermal hypersensitivity in Sarm1(-\/-) mice","volume":"338","author":"Gould","year":"2021","journal-title":"Exp Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"113636","DOI":"10.1016\/j.expneurol.2021.113636","article-title":"SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration","volume":"339","author":"Chen","year":"2021","journal-title":"Exp Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00520-013-1981-6","article-title":"Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children","volume":"22","author":"Gilchrist","year":"2014","journal-title":"Support Care Cancer."},{"key":"B101","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1111\/jns.12333","article-title":"Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity","volume":"24","author":"Park","year":"2019","journal-title":"J Peripher Nerv Syst."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e01312","DOI":"10.1002\/brb3.1312","article-title":"Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy","volume":"9","author":"Molassiotis","year":"2019","journal-title":"Brain Behav."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1007\/s00520-019-04781-6","article-title":"Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade","volume":"27","author":"Tan","year":"2019","journal-title":"Support Care Cancer."},{"key":"B104","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdt409","article-title":"Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin","volume":"25","author":"Alberti","year":"2014","journal-title":"Ann Oncol."}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.864910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:44:34Z","timestamp":1647218674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.864910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":104,"alternative-id":["10.3389\/fpain.2022.864910"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2022.864910","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"article-number":"864910"}}